Impact of initial aggressive drug treatment with a combination of disease‐modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five‐year randomized followup trial

Puolakka, Kari; Kautiainen, Hannu; Möttönen, Timo; Hannonen, Pekka; Korpela, Markku; Julkunen, Heikki; Luukkainen, Reijo; Vuori, Kaisa; Paimela, Leena; Blåfield, Harri; Hakala, Markku; Leirisalo‐Repo, Marjatta

doi:10.1002/art.11436

Public

Impact of initial aggressive drug treatment with a combination of disease‐modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five‐year randomized followup trial

Published in Arthritis & Rheumatism • Jan 1, 2004

Authors:

Kari Puolakka

Hannu Kautiainen

Timo Möttönen

Abstract

OBJECTIVE: To compare the efficacy of therapy with a combination of disease-modifying antirheumatic drugs (DMARDs) versus therapy with a single DMARD in the prevention of work disability in patients with early rheumatoid arthritis (RA). METHODS: In the Finnish Rheumatoid Arthritis Combination Therap...

Subject

Medicine

Rheumatoid arthritis

Prednisolone

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!